Has Brexit Hindered Biosimilar Development?
Season 4 Episode 10 · Apr 04, 2021, 11:00 AM
Share
Subscribe
Maria Manley, LLM, a life sciences expert, talks about how the United Kingdom’s exit from the European Union has changed the regulatory landscape for biologics.
To learn more about Brexit's impact on the biologics industry, click here.